Ian A. Blair
A.N. Richards Professor of Pharmacology
Director, Center for Cancer Pharmacology, University of Pennsylvania School of Medicine
Investigator, Abramson Cancer Center, University of Pennsylvania School of Medicine
Member, Institute for Medicine and Engineering, University of Pennsylvania School of Medicine
Investigator, Genomics Institute, University of Pennsylvania School of Medicine
Scientific Director, Proteomics Core Laboratory, Genomics Institute and Abramson Cancer Center, University of Pennsylvania School of Medicine
Vice Chair, Department of Pharmacology, University of Pennsylvania School of Medicine
Scientific Director, Mass Spectrometry Facility, Department of Chemistry, University of Pennsylvania
Director, Program in Systems Biology, Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine
Member, Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine
Department: Pharmacology
Contact information
854 Biomedical Research Building II/III
University of Pennsylvania School of Medicine
Center for Cancer Pharmacology
421 Curie Boulevard
Philadelphia, PA 19104-6160
University of Pennsylvania School of Medicine
Center for Cancer Pharmacology
421 Curie Boulevard
Philadelphia, PA 19104-6160
Office: (215) 573-9880
Fax: (215) 573-9889
Fax: (215) 573-9889
Email:
ianblair@mail.med.upenn.edu
ianblair@mail.med.upenn.edu
Graduate Group Affiliations
Publications
Education:
Cambridge Grammar School for Boys, United Kingdom , 1960.
Prince of Wales School, Nairobi, Kenya, 1963.
B.Sc. ((Special) Chemistry, ARCS)
Imperial College of Science and Technology, University of London, United Kingdom, 1968.
Ph.D.
Imperial College of Science and Technology, University of London, United Kingdom, 1971.
MRSC (Organic Chemistry)
Adelaide University, Australia, 1972.
ARACI
Australian National University, 1977.
Cambridge Grammar School for Boys, United Kingdom , 1960.
Prince of Wales School, Nairobi, Kenya, 1963.
B.Sc. ((Special) Chemistry, ARCS)
Imperial College of Science and Technology, University of London, United Kingdom, 1968.
Ph.D.
Imperial College of Science and Technology, University of London, United Kingdom, 1971.
MRSC (Organic Chemistry)
Adelaide University, Australia, 1972.
ARACI
Australian National University, 1977.
Links
Search PubMed for articles
Center for Cancer Pharmacology, Blair Lab webpage. Department of Pharmacology, Faculty Webpage
Permanent linkSearch PubMed for articles
Center for Cancer Pharmacology, Blair Lab webpage. Department of Pharmacology, Faculty Webpage
Description of Research Expertise
Oxidative stress, carcinogenesis, cardiovascular disease, and neurodegenerative diseaseOxidative stress results in damage to lipids through the formation of lipid hydroperoxides. Our laboratory is involved in determining the factors that control lipid hydroperoxide-mediated damage to DNA, and proteins. We are also characterizing the lesions in these macromolecules using novel mass spectrometry methodology, determining how the lesions affect proliferation and apoptosis using model in vitro systems, and assessing how such processes can be prevented using novel pharmacological agents. We also have a program in biomarker discovery and analysis, which is focused on metabolomic and proteomic biomarkers of smoking, pancreatic cancer, breast cancer, and neurodegenerative diseases. This involves the use of quantitative stable isotope dilution liquid chromatography-mass spectrometry methodology. We recently implement the use of stable isotope dilution by essential nutrients in cell culture (SILEC) as a method for analyzing important Krebs cycle coenzyme A-thioesters. This has made it possible to examine the effects of chemicals and disease on mitochondrial dysfunction.
Description of Itmat Expertise
Dr. Blair is interested in oxidative stress in cancer, cardiovascular disease, and neurodegenerative disease including the investigation of the role of endogenous DNA- and glutathione-adducts as biomarkers of cancer and cardiovascular disease in vitro, in animal models and humans. He is also developing metabolomic biomarkers of neurodegenerative diseases in humans and in animal models.Selected Publications
Tamae D, Byrns M, Marck B, Mostaghel EA, Nelson PS, Lange P, Lin D, Taplin ME, Balk S, Ellis W, True L, Vessella R, Montgomery B, Blair IA, Penning TM. : Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serum. J Steroid Biochem Mol Biol. 138C: 281-289, July 2013.Lee I, Dodia C, Chatterjee S, Zagorski J, Mesaros C, Blair IA, Feinstein SI, Jain M, Fisher AB.: A novel non-toxic inhibitor of the activation of NADPH oxidase (NOX2) reduces reactive oxygen species production in mouse lung. J Pharmacol Exp Ther. 345(2): 284-96, 2013.
Strasser AA, Ashare RL, Kaufman M, Tang KZ, Mesaros C, Blair IA: The effect of menthol on cigarette smoking behaviors, biomarkers and subjective responses. Cancer Epidemiol Biomarkers Prev. 22(3): 382-389, 2013.
Snyder N, Khezam M, Mesaros AC, Worth A, and Blair IA. : Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography- High Resolution Mass Spectrometry (UPLC-HRMS). J Vis Exp.(75), 2013 Notes: doi: 10.3791/50433.
Huang M, Blair IA, Penning TM. : Identification of stable benzo[a]pyrene-7,8-dione-DNA adducts in human lung cells. Chem Res Toxicol 26(5): 685-692, 2013.
Hammons AL, Summers CM, Jochems J, Arora JS, Zhang S, Blair IA, Whitehead AS. : Pemetrexed alters folate phenotype and inflammatory profile in EA.hy 926 cells grown under low-folate conditions. Eur J Pharmacol 696(1-3): 12-17, Dec 2012.
Hood ED, Greineder CF, Dodia C, Han J, Mesaros C, Shuvaev VV, Blair IA, Fisher AB, Muzykantov VR: Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo. J Control Release 163(2): 161-169, Oct 2012.
MacDonald ML, Ciccimaro E, Prakash A, Banerjee A, Seeholzer SH, Blair IA, Hahn CG: Biochemical Fractionation and Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry for Targeted and Microdomain-Specific Protein Quantification in Human Postmortem Brain Tissue. Mol Cell Proteomics 11(12): 1670-1681, Aug 2012.
Zhang L, Huang M, Blair IA, Penning TM: Detoxication of Benzo[a]pyrene-7,8-dione by Sulfotransferases (SULT) in Human Lung Cells. J. Biol. Chem 287(35): 29909-20, Jul 2012.
Ashare RL, Tang KZ, Mesaros AC, Blair IA, Leone FT, Strasser AA. (2012) : Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers. J Psychopharmacol 10: 1383-90, June 2012.

